Corporate Glenmark Pharmaceuticals Limited March 21, 2026 Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325. |SUBJECT: Press Release Post navigation Poonawalla Fincorp Limited Poonawalla Fincorp Limited Related Posts Fedbank Financial Services Limited Fedbank Financial Services Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor… March 4, 2026 TATA CONSUMER PRODUCTS LIMITED Tata Consumer Products Limited has informed the Exchange about Notice of Shareholders Meeting for Annual… May 17, 2026 Kilitch Drugs (India) Limited KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on… May 7, 2026 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Fedbank Financial Services Limited Fedbank Financial Services Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor… March 4, 2026
TATA CONSUMER PRODUCTS LIMITED Tata Consumer Products Limited has informed the Exchange about Notice of Shareholders Meeting for Annual… May 17, 2026
Kilitch Drugs (India) Limited KILITCH DRUGS (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on… May 7, 2026
